Business Description
Arch Therapeutics Inc
NAICS : 325413
SIC : 2836
ISIN : US03939W2089
Description
Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The company's primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -99.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -2484.56 | |||||
OCF Margin % | -2484.56 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 0.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ARTHQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arch Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.149 | ||
| EPS (TTM) ($) | -2.864 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.43 | ||
| 3-Year Sortino Ratio | 2.32 | ||
| Volatility % | 826.46 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -99.95 | ||
| 52-Week Range ($) | 0.0001 - 0.2899 | ||
| Shares Outstanding (Mil) | 4.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arch Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arch Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-08-19 | In 51 days | ||
| Second quarter earnings results for 2026 | 2026-05-15 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-02-16 | 0.00 (+0.00%) | ||
| General meeting for 2025 | 2026-01-30 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2026-01-27 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-01-20 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-01-13 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2026-01-06 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2024 | 2024-08-19 | 0.67 (+3.91%) | ||
| 0.005:1 Stock Split | 2023-01-18 | 6.40 (+4.07%) |
Show
Entries
Arch Therapeutics Inc Frequently Asked Questions
What is Arch Therapeutics Inc(ARTHQ)'s stock price today?
The current price of ARTHQ is $0.00. The 52 week high of ARTHQ is $0.29 and 52 week low is $0.00.
When is next earnings date of Arch Therapeutics Inc(ARTHQ)?
The next earnings date of Arch Therapeutics Inc(ARTHQ) is 2026-08-19 Est..
Does Arch Therapeutics Inc(ARTHQ) pay dividends? If so, how much?
Arch Therapeutics Inc(ARTHQ) does not pay dividend.
Guru Commentaries on OTCPK:ARTHQ
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Arch Therapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers